Balance Sheet for BioMarin Pharmaceutical Inc. (BMRN)

$ 79.92   -0.16 (-0.20%) Volume: 1.1m 4:00 PM EST 6-Dec-2019
After Hours:  $ 80.50   0.58 (+0.73%) Volume: 42.28k 6:15 PM EST 6-Dec-2019
Statement: View:
Assets [+] in Millions of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 494 598 408 397 875
Restrictable Cash - - - 7 2
Marketable Securities 590 798 381 196 70
Accounts Receivable 343 261 215 165 144
Loans Receivable - - - - -
Other Receivables - - - 14 10
Receivables 343 261 215 165 201
Inventories, Raw Materials 75 50 51 46 22
Inventories, Work in Progress 231 235 168 150 114
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 225 191 136 75 63
Inventories, Other 531 476 355 272 199
Inventories, Adjustments & Allowances - - - - -
Inventories 531 476 355 272 199
Prepaid Expenses - - - 28 35
Current Deferred Income Taxes - - - 93 31
Other Current Assets 98 74 62 60 1
Total Current Assets 2,056 2,207 1,422 1,090 1,398
Land and Improvements 85 68 60 51 33
Buildings and Improvement 736 706 555 486 375
Machinery, Furniture and Equipment 537 470 400 282 235
Construction in Progress 64 60 126 164 108
Fixed Assets, Other - - - - -
Fixed Assets, Total 1,421 1,303 1,141 983 752
Gross Fixed Assets 1,421 1,303 1,141 983 752
Accumulated Depreciation (473) (407) (343) (279) (229)
Net Fixed Assets 949 897 799 704 524
Intangibles 492 518 554 684 157
Cost in Excess 197 197 197 197 54
Non-Current Deferred Income Taxes 461 399 447 220 191
Other Non-Current Assets 37 30 33 7 6
Total Non-Current Assets 2,371 2,426 2,602 2,640 1,078
Total Assets 4,427 4,633 4,024 3,729 2,475
Liabilities [+] in Millions of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 361 291 295 266 164
Short Term Debt 1,109 361 22 - -
Notes Payable - - - - -
Accrued Expenses - - - 18 8
Accrued Liabilities - - - 18 8
Deferred Revenues - 17 - - -
Current Deferred Income Taxes (68) 44 (228) (77) (25)
Other Current Liabilities (947) 148 122 161 63
Total Current Liabilities 523 817 439 445 236
Long Term Debt 830 814 661 662 643
Deferred Income Tax - - - 144 -
Other Non-Current Liabilities 106 194 157 77 69
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 936 1,008 818 883 712
Total Liabilities 1,459 1,824 1,257 1,329 947
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 2,968 2,809 2,766 2,401 1,528
Common Par 0 0 0 0 0
Additional Paid in Capital 4,670 4,483 4,288 3,415 2,360
Cumulative Translation Adjustments - - - - -
Retained Earnings (1,694) (1,638) (1,521) (1,022) (850)
Treasury Stock 13 14 14 14 10
Other Equity Adjustments 5 (23) 13 21 27
Total Capitalization 3,798 3,622 3,427 3,063 2,171
Total Equity 2,968 2,809 2,766 2,401 1,528
Total Liabilities & Shareholder's Equity 4,427 4,633 4,024 3,729 2,475
Cash Flow (173) (208) (728) (221) (198)
Working Capital 1,533 1,391 982 644 1,162
Free Cash Flow (124) (208) (376) (449) (192)
Invested Capital 3,798 3,622 3,427 3,063 2,171
Shares Outstanding - Common Class Only 178 176 173 162 149
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 178 176 173 162 149
Total Common Shares Outstanding 178 176 173 162 149
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 177 174 166 160 146
Diluted Weighted Shares Outstanding 177 174 166 160 146